Valproate and of risk of abnormal pregnancy outcomes: new communication materials
Children exposed to valproate in utero are at high risk of developmental disorders and congenital malformations.
Spironolactone and renin-angiotensin system drugs in heart failure: risk of potentially fatal hyperkalaemia
Monitoring of blood electrolytes is essential in patients coprescribed a potassium-sparing diuretic and an angiotensin converting enzyme inhibitor (ACEi) or an angiotensin receptor blocker (ARB) for heart failure.
Letters sent to healthcare professionals in January 2016
In January 2016, letters were sent to healthcare professionals regarding fingolimod (Gilenya▼) and erlotinib (Tarceva)